Clinical Trials Browser

Has results × Neurologic Manifestations × Temozolomide × Clear all

NCT02343549 2022-11-03

A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)

Phase 2 Terminated

13 enrolled 23 charts

Brain Neoplasms, Neurologic Manifestations

NCT01120639 2021-08-06

Tx-Treatment

Phase 1/2 Completed

30 enrolled 19 charts

Brain Neoplasms, Glioblastoma, Neurologic Manifestations